(S1 (S (S (NP (NP (DT The) (NNS merits)) (PP (IN of) (NP (JJ vascular) (NN targeting))) (PP (IN for) (NP (NN gynecologic) (NNS malignancies))))) (. .)))
(S1 (S (S (NP (NN Neovascularization)) (VP (VBZ is) (NP (NP (DT an) (ADJP (ADJP (JJ early)) (CC and) (ADJP (JJ critical))) (NN step)) (PP (IN in) (NP (NP (NN tumor) (NN development)) (CC and) (NP (NN progression))))))) (. .)))
(S1 (S (S (NP (NN Tumor) (NNS vessels)) (VP (VBP are) (ADJP (JJ distinct) (PP (IN from) (NP (PRP$ their) (JJ normal) (NNS counterparts)))) (PP (ADVP (RB morphologically)) (CONJP (RB as) (RB well) (IN as)) (PP (IN at) (NP (DT a) (JJ molecular) (NN level)))))) (. .)))
(S1 (S (S (NP (NP (JJ Recent) (NNS studies)) (PP (IN on) (NP (NP (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (NN tumor) (JJ vascular) (NN development))))))) (VP (VBP have) (VP (VBN identified) (NP (NP (JJ new) (JJ therapeutic) (NNS targets)) (PP (IN for) (S (VP (VBG inhibiting) (NP (NP (NN tumor) (NN neovascularization)) (CC and) (ADVP (RB thus)) (NP (NN tumor) (NN progression)))))))))) (. .)))
(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NN tumor) (NN blood) (NN vessel) (NN formation)))) (VP (VBZ is) (NP (NN complex)))) (, ,) (CC and) (S (NP (DT each) (NN tumor)) (VP (VBZ exhibits) (NP (JJ unique) (NNS features)) (PP (IN in) (NP (PRP$ its) (NN vasculature)))))) (. .)))
(S1 (S (S (NP (NP (DT An) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ relative) (NN contribution)) (PP (IN of) (NP (JJ various) (NNS pathways))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN tumor) (NN vasculature)))))))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (S (VP (VBG developing) (NP (ADJP (ADJP (JJ effective)) (CC and) (ADJP (JJ selective))) (JJ therapeutic) (NNS approaches)))))))) (. .)))
(S1 (S (S (S (NP (JJ Several) (JJ such) (NNS agents)) (VP (VBP are) (ADVP (RB currently)) (PP (IN in) (NP (JJ clinical) (NNS trials))))) (, ,) (CC and) (S (NP (JJ many) (NNS others)) (VP (VBP are) (PP (IN under) (NP (NN development)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN review))) (, ,) (NP (NP (DT the) (NP (NNS mechanisms)) (CC and) (NP (NNS factors))) (VP (VBN involved) (PP (IN in) (NP (NN tumor) (NN blood) (NN vessel) (NN formation))))) (VP (VBP are) (VP (VBN discussed)))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (VBN selected) (JJ novel) (NNS classes)) (PP (IN of) (NP (NN antivascular) (NNS therapies))) (, ,) (PP (VBG including) (NP (NP (DT those) (NN targeting) (NN tumor) (JJ endothelial) (NNS cells)) (CC and) (NP (NP (JJ other) (NNS components)) (PP (IN of) (NP (DT the) (NN tumor) (NN vasculature)))))) (, ,)) (VP (VBP are) (VP (VBN summarized)))) (. .)))
